▶ 調査レポート

病気管理&予防ワクチンの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Disease Control and Prevention Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。病気管理&予防ワクチンの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Disease Control and Prevention Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-05225資料のイメージです。• レポートコード:D005-05225
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥382,800 (USD3,480)▷ お問い合わせ
  Multi User¥574,200 (USD5,220)▷ お問い合わせ
  Corporate User¥765,600 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、病気管理&予防ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。病気管理&予防ワクチンの種類別市場規模(ライブ減衰、不活性化、組換えサブユニット&トキソイド)、用途別市場規模(小児用ワクチン、成人用ワクチン)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GSK、Serum Institute of India Pvt. Ltd、Sanofi、Merck & Co., Inc、Astellas Pharma Inc、Pfizer、Sinovac Biotech Ltd、AstraZeneca PLC、Daiichi Sankyo
・地域別グローバル市場分析 2015年-2020年
・病気管理&予防ワクチンの北米市場(アメリカ、カナダ、メキシコ)
・病気管理&予防ワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・病気管理&予防ワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・病気管理&予防ワクチンの南米市場(ブラジル、アルゼンチン)
・病気管理&予防ワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ライブ減衰、不活性化、組換えサブユニット&トキソイド
・用途別分析:小児用ワクチン、成人用ワクチン
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Disease Control and Prevention Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 55270 million by 2025, from USD 42850 million in 2019.

The Disease Control and Prevention Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Disease Control and Prevention Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Disease Control and Prevention Vaccine market has been segmented into
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid

By Application, Disease Control and Prevention Vaccine has been segmented into:
Pediatric Vaccine
Adult Vaccine

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Disease Control and Prevention Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Disease Control and Prevention Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Disease Control and Prevention Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Disease Control and Prevention Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Disease Control and Prevention Vaccine Market Share Analysis
Disease Control and Prevention Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Disease Control and Prevention Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Disease Control and Prevention Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Disease Control and Prevention Vaccine are:
GSK
Serum Institute of India Pvt. Ltd
Sanofi
Merck & Co., Inc
Astellas Pharma Inc
Pfizer
Sinovac Biotech Ltd
AstraZeneca PLC
Daiichi Sankyo

Among other players domestic and global, Disease Control and Prevention Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Disease Control and Prevention Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Disease Control and Prevention Vaccine, with price, sales, revenue and global market share of Disease Control and Prevention Vaccine in 2018 and 2019.
Chapter 3, the Disease Control and Prevention Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Disease Control and Prevention Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Disease Control and Prevention Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Disease Control and Prevention Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Disease Control and Prevention Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Disease Control and Prevention Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Live-Attenuated
1.2.3 Inactivated
1.2.4 Recombinant Sub Unit and Toxoid
1.3 Market Analysis by Application
1.3.1 Overview: Global Disease Control and Prevention Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 Overview of Global Disease Control and Prevention Vaccine Market
1.4.1 Global Disease Control and Prevention Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Serum Institute of India Pvt. Ltd
2.2.1 Serum Institute of India Pvt. Ltd Details
2.2.2 Serum Institute of India Pvt. Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Serum Institute of India Pvt. Ltd SWOT Analysis
2.2.4 Serum Institute of India Pvt. Ltd Product and Services
2.2.5 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck & Co., Inc
2.4.1 Merck & Co., Inc Details
2.4.2 Merck & Co., Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck & Co., Inc SWOT Analysis
2.4.4 Merck & Co., Inc Product and Services
2.4.5 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Astellas Pharma Inc
2.5.1 Astellas Pharma Inc Details
2.5.2 Astellas Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Astellas Pharma Inc SWOT Analysis
2.5.4 Astellas Pharma Inc Product and Services
2.5.5 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sinovac Biotech Ltd
2.7.1 Sinovac Biotech Ltd Details
2.7.2 Sinovac Biotech Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sinovac Biotech Ltd SWOT Analysis
2.7.4 Sinovac Biotech Ltd Product and Services
2.7.5 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca PLC
2.8.1 AstraZeneca PLC Details
2.8.2 AstraZeneca PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca PLC SWOT Analysis
2.8.4 AstraZeneca PLC Product and Services
2.8.5 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Daiichi Sankyo SWOT Analysis
2.9.4 Daiichi Sankyo Product and Services
2.9.5 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Disease Control and Prevention Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Disease Control and Prevention Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Disease Control and Prevention Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Disease Control and Prevention Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Disease Control and Prevention Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Disease Control and Prevention Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
6.4 France Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Disease Control and Prevention Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
7.5 India Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Disease Control and Prevention Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Disease Control and Prevention Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Disease Control and Prevention Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Disease Control and Prevention Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Disease Control and Prevention Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Disease Control and Prevention Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Disease Control and Prevention Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Disease Control and Prevention Vaccine Price by Type (2015-2020)
11 Global Disease Control and Prevention Vaccine Market Segment by Application
11.1 Global Disease Control and Prevention Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Disease Control and Prevention Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Disease Control and Prevention Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Disease Control and Prevention Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Disease Control and Prevention Vaccine Market Forecast (2021-2025)
12.2.2 Europe Disease Control and Prevention Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Disease Control and Prevention Vaccine Market Forecast (2021-2025)
12.2.4 South America Disease Control and Prevention Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Disease Control and Prevention Vaccine Market Forecast (2021-2025)
12.3 Disease Control and Prevention Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Disease Control and Prevention Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Disease Control and Prevention Vaccine Market Share Forecast by Type (2021-2025)
12.4 Disease Control and Prevention Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Disease Control and Prevention Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Disease Control and Prevention Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Disease Control and Prevention Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Disease Control and Prevention Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Disease Control and Prevention Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Disease Control and Prevention Vaccine Major Business
Table 9. GSK Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Disease Control and Prevention Vaccine Product and Services
Table 12. GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Major Business
Table 15. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Serum Institute of India Pvt. Ltd SWOT Analysis
Table 17. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product and Services
Table 18. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Disease Control and Prevention Vaccine Major Business
Table 21. Sanofi Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Sanofi SWOT Analysis
Table 23. Sanofi Disease Control and Prevention Vaccine Product and Services
Table 24. Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 26. Merck & Co., Inc Disease Control and Prevention Vaccine Major Business
Table 27. Merck & Co., Inc Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Merck & Co., Inc SWOT Analysis
Table 29. Merck & Co., Inc Disease Control and Prevention Vaccine Product and Services
Table 30. Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 32. Astellas Pharma Inc Disease Control and Prevention Vaccine Major Business
Table 33. Astellas Pharma Inc Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Astellas Pharma Inc SWOT Analysis
Table 35. Astellas Pharma Inc Disease Control and Prevention Vaccine Product and Services
Table 36. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Disease Control and Prevention Vaccine Major Business
Table 39. Pfizer Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Disease Control and Prevention Vaccine Product and Services
Table 42. Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sinovac Biotech Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Major Business
Table 45. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Sinovac Biotech Ltd SWOT Analysis
Table 47. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product and Services
Table 48. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AstraZeneca PLC Basic Information, Manufacturing Base and Competitors
Table 50. AstraZeneca PLC Disease Control and Prevention Vaccine Major Business
Table 51. AstraZeneca PLC Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. AstraZeneca PLC SWOT Analysis
Table 53. AstraZeneca PLC Disease Control and Prevention Vaccine Product and Services
Table 54. AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 56. Daiichi Sankyo Disease Control and Prevention Vaccine Major Business
Table 57. Daiichi Sankyo Disease Control and Prevention Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Daiichi Sankyo SWOT Analysis
Table 59. Daiichi Sankyo Disease Control and Prevention Vaccine Product and Services
Table 60. Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Disease Control and Prevention Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Disease Control and Prevention Vaccine Sales by Regions (2015-2020) (K Units)
Table 64. Global Disease Control and Prevention Vaccine Sales Market Share by Regions (2015-2020)
Table 65. Global Disease Control and Prevention Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Disease Control and Prevention Vaccine Sales by Countries (2015-2020) (K Units)
Table 67. North America Disease Control and Prevention Vaccine Sales Market Share by Countries (2015-2020)
Table 68. North America Disease Control and Prevention Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2015-2020)
Table 70. Europe Disease Control and Prevention Vaccine Sales by Countries (2015-2020) (K Units)
Table 71. Europe Disease Control and Prevention Vaccine Sales Market Share by Countries (2015-2020)
Table 72. Europe Disease Control and Prevention Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Disease Control and Prevention Vaccine Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Disease Control and Prevention Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Disease Control and Prevention Vaccine Sales by Countries (2015-2020) (K Units)
Table 77. South America Disease Control and Prevention Vaccine Sales Market Share by Countries (2015-2020)
Table 78. South America Disease Control and Prevention Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Disease Control and Prevention Vaccine Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries (2015-2020)
Table 84. Global Disease Control and Prevention Vaccine Sales by Type (2015-2020) (K Units)
Table 85. Global Disease Control and Prevention Vaccine Sales Share by Type (2015-2020)
Table 86. Global Disease Control and Prevention Vaccine Revenue by Type (2015-2020) (USD Million)
Table 87. Global Disease Control and Prevention Vaccine Revenue Share by Type (2015-2020)
Table 88. Global Disease Control and Prevention Vaccine Sales by Application (2015-2020) (K Units)
Table 89. Global Disease Control and Prevention Vaccine Sales Share by Application (2015-2020)
Table 90. Global Disease Control and Prevention Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Disease Control and Prevention Vaccine Market Share Forecast by Regions (2021-2025)
Table 92. Global Disease Control and Prevention Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Disease Control and Prevention Vaccine Market Share Forecast by Type (2021-2025)
Table 94. Global Disease Control and Prevention Vaccine Sales Forecast by Application (2021-2025)
Table 95. Global Disease Control and Prevention Vaccine Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Disease Control and Prevention Vaccine Picture
Figure 2. Global Sales Market Share of Disease Control and Prevention Vaccine by Type in 2019
Figure 3. Live-Attenuated Picture
Figure 4. Inactivated Picture
Figure 5. Recombinant Sub Unit and Toxoid Picture
Figure 6. Disease Control and Prevention Vaccine Sales Market Share by Application in 2018
Figure 7. Pediatric Vaccine Picture
Figure 8. Adult Vaccine Picture
Figure 9. Global Disease Control and Prevention Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Disease Control and Prevention Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Disease Control and Prevention Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Disease Control and Prevention Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Disease Control and Prevention Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Disease Control and Prevention Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Disease Control and Prevention Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Disease Control and Prevention Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Disease Control and Prevention Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Disease Control and Prevention Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Regions 2019
Figure 62. China Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Disease Control and Prevention Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Disease Control and Prevention Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Disease Control and Prevention Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Disease Control and Prevention Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Disease Control and Prevention Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Disease Control and Prevention Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Disease Control and Prevention Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Disease Control and Prevention Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Disease Control and Prevention Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Disease Control and Prevention Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Disease Control and Prevention Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel